The formulation of biopharmaceutical products.

The formulation of biopharmaceutical products.

Item
http://www.wikidata.org/entity/Q33885400
Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.Overview of drug product development.Analytical methods and formulation factors to enhance protein stability in solution.Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primerDevelopment of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Lack of a synergistic effect of arginine-glutamic acid on the physical stability of spray-dried bovine serum albumin.Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.
P2860

The formulation of biopharmaceutical products.

Item
http://www.wikidata.org/entity/Q33885400
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The formulation of biopharmaceutical products.
@ast
The formulation of biopharmaceutical products.
@en
type
label
The formulation of biopharmaceutical products.
@ast
The formulation of biopharmaceutical products.
@en
prefLabel
The formulation of biopharmaceutical products.
@ast
The formulation of biopharmaceutical products.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
The formulation of biopharmaceutical products.
@en
P2093
P304
P31
P356
10.1016/S1461-5347(00)00248-0
P433
P478
P577
P698